Protein Kinase Inhibitors: From Discovery to Therapeutics

ISBN-13: 9780323912877 / Angielski / Miękka / 2022

MD Imtaiyaz Hassan; Saba Noor

Spis treści

1. Kinase Inhibitors: An Overview 2. Protein Kinase Inhibitors and cancer targeted therapy 3. Drug discovery for cancer therapy with special reference to inhibitors of protein kinase pathway 4. An insight on PI3K/Akt/mTOR inhibitors in cancer: opportunity and translational perspectives 5. Recent advances in the therapeutic development of ERK inhibitors 6. Emerging small-molecule inhibitors of ATM kinase targeting cancer therapy 7. Targeting Pyruvate Kinase M2 Signaling for Development of Effective Cancer Therapy 8. Serum and glucocorticoid-regulated kinase 1: A potential target for anticancer therapy 9. AKT inhibitors in cancer therapy 10. Aurora kinase: An emerging potential target in therapeutics 11. The Retroactive and Future Potentials of Aurora Kinases in the Treatment of Cancer 12. Targeting the altered tyrosine kinases in colorectal cancer: from inhibitors to drugs 13. PTEN-induced kinase1 (PINK1): Structure, Functions and Role in Human Disease 14. Rho associated protein kinase 1 and 2 (ROCK1&ROCK2) as a potential emerging therapeutic drug target in Alzheimer's disease 15. PDK inhibitors as therapeutic agents: An Overview 16. Polo-like kinases (PLKs): an antimitotic target 17. Src Kinase: An Attractive Therapeutic Target for Prostate Cancer 18. Kinase inhibition in Alzheimer's disease 19. Therapeutic Targeting of Glycogen Synthase Kinase-3: Strategy to address neurodegenerative diseases 20. Microtubule Affinity Regulating Kinase 4: a potential drug target from cancers to neurodegenerative diseases 21. Receptor tyrosine kinase-like orphan receptors ROR1/2: Insights into the mechanism of action, inhibition, and therapeutic potentialIndrakant 22. Therapeutic Potential of Leucine Rich Repeat Kinase 2 (LRRK2) Inhibitors for Parkinson's Disease Treatment 23. Calcium calmodulin dependent protein kinase as potential drug target 24. Therapeutics of Platelet derived growth factor (PDGF) and signaling in different organs 25. EGFRC797S mutation and fourth generation EGFR tyrosine kinase inhibitors (EGFR-TKIs) 26. Bacterial Histidine Kinases as potential Antibacterial Drug Targets 27. Bacterial Protein Kinases: a target to inhibit the bacterial infections 28. Nanotechnology-based targeted delivery systems for Protein Kinase inhibitors in Cancer therapy